Skip to main content
letter
. 2020 Jul 8;81(3):e12–e15. doi: 10.1016/j.jinf.2020.07.010

Table 1.

Baseline characteristics of coronavirus disease 2019 (COVID-19) and M. pneumoniae co-infection patients.

Characteristics COVID-19 mono-infection patients (n = 88) COVID-19 patients co-infection with M. pneumoniae (n = 22) p
Baseline
Age (years) 57.00 (46.50–65.00) 56.50 (52.50–66.50) 0.726
Male 45 (51.1) 11 (50.0) 1.000
Time from illness onset to hospital admission (days) 10.50 (7.00–20.00) 14.50 (5.50–20.00) 0.666
Comorbidities
Diabetes 20 (22.7) 5 (22.7) 1.000
Hyperlipemia 3 (3.4) 1 (4.5) 1.000
Hypertension 16 (18.2) 4 (18.2) 1.000
Chronic heart failure 2 (2.3) 1 (4.5) 1.000
Liver cirrhosis 2 (2.3) 2 (9.1) 0.373
Anemia 6 (6.8) 2 (9.1) 1.000
Chronic kidney diseases 1 (1.1) 1 (4.5) 0.858
Rheumatoid arthritis 0 (0.0) 2 (9.1) 0.05
Cerebrovascular disease 1 (1.1) 1 (4.5) 0.858
Myasthenia Gravis 1 (1.1) 1 (4.5) 0.858
Deep venous thrombosis 0 (0.0) 1 (4.5) 0.451
COPD 6 (6.8) 1 (4.5) 1.000
Symptoms
Fever 55 (62.5) 10 (45.5) 0.226
Cough 27 (30.7) 4 (18.2) 0.368
Dyspnea 7 (8.0) 2 (9.1) 1.000
Fatigue 6 (6.8) 4 (18.2) 0.214
Diarrhea 2 (2.3) 2 (9.1) 0.373
Chestpain 1 (1.1) 0 (0.0) 1.000
Dizzy 0 (0.0) 1 (4.5) 0.451
other 11 (12.5) 4 (18.2) 0.728
Signs
Respiratory rate 36.70 (36.50–37.02) 36.50 (36.30–36.98) 0.096
Heart rate 86.00 (79.75–97.25) 94.00 (79.25–98.50) 0.437
Systolic pressure (mmHg) 20.00 (18.00–20.00) 19.50 (18.00–20.00) 0.273
Diastolic pressure (mmHg) 130.00 (120.00–139.25) 127.00 (116.00–143.25) 0.672
Peripheral oxygen saturation (%) 80.00 (73.50–87.00) 82.50 (72.75–88.50) 0.624
Laboratory tests
White blood cell count (× 109/L) 5.63 (4.90–7.08) 5.81 (5.13–6.84) 0.627
Neutrophil count (× 109/L) 3.55 (2.91–5.19) 3.35 (2.64–5.43) 0.725
Lymphocyte count (× 109/L) 1.35 (0.91–1.73) 1.63 (1.20–2.04) 0.167
Monocyte count (× 109/L) 0.39 (0.31–0.51) 0.38 (0.33–0.56) 0.257
Hemoglobin (g/L) 131.00 (119.00–142.00) 123.00 (118.50–130.50) 0.087
Platelet count (× 109/L) 204.00 (165.75–258.25) 187.50 (144.00–250.25) 0.269
Albumin (g/L) 39.90 (36.90–43.85) 41.65 (36.12–43.05) 0.858
Alanine aminotransferase (ALT) (U/L) 22.70 (15.10–33.15) 23.15 (13.98–33.23) 0.949
Aspartate aminotransferase (AST) (U/L) 19.60 (15.00–26.25) 19.30 (14.53–23.70) 0.834
Direct Bilirubin (μmol/L) 3.28 ± 2.15 19.19 ± 72.26 0.039
Indirect Bilirubin (μmol/L) 8.03 ± 4.07 14.67 ± 28.72 0.037
Creatine (μmol/L) 68.15 (55.82–88.95) 56.70 (50.48–72.72) 0.057
Urea (mmol/L) 4.50 (3.83–5.60) 4.21 (3.34–4.54) 0.151
Creatine kinase (U/L) 70.50 (49.75–115.75) 66.00 (48.75–78.75) 0.279
Creatine kinase -MB (U/L) 6.00 (5.00–9.00) 7.15 (5.00–11.40) 0.324
Troponin (ng/mL) 0.00 (0.00–0.01) 0.01 (0.00–0.03) 0.12
Brain Natriuretic Peptid (pg/mL) 32.50 (14.88–85.75) 58.50 (20.75–126.85) 0.245
Lactate dehydrogenase (U/L) 156.00 (138.00–194.75) 177.00 (141.00–208.25) 0.52
Blood glucose (mmol/L) 5.29 (4.70–6.99) 5.55 (5.12–7.25) 0.358
Sodium (mmol/L) 140.00 (137.57–142.00) 139.50 (138.00–140.90) 0.386
Potassium (mmol/L) 4.21 (3.97–4.50) 4.16 (4.01–4.39) 0.572
Calcium (mmol/L) 2.29 (2.19–2.45) 2.38 (2.28–2.45) 0.188
Chloride (mmol/L) 103.30 (102.02–106.40) 104.20 (101.17–106.48) 0.934
Phosphorus (mmol/L) 1.09 (0.93–1.22) 1.11 (0.98–1.22) 0.731
Prothrombin Time (s) 13.34 ± 5.40 11.60 ± 0.84 0.004
International Normalized Ratio 1.16 ± 0.50 1.00 ± 0.08 0.005
Prothrombin Activity (%) 89.78 ± 30.65 104.90 ± 20.14 0.006
Activated Partial Thromboplastin Time (s) 31.07 ± 8.88 28.53 ± 5.15 0.082
Thrombin Time (s) 16.95 ± 1.79 16.88 ± 1.54 0.86
Fibrinogen (g/L) 2.52 (2.17–3.05) 2.37 (2.09–2.60) 0.121
D-dimer (ug/mL) 0.45 (0.25–1.02) 0.72 (0.44–1.61) 0.062
Interleukin-6 (pg/mL) 4.49 (2.26–12.34) 2.90 (2.08–5.89) 0.138
Procalcitonin (ng/ml) 0.05 (0.04–0.08) 0.05 (0.03–0.07) 0.382
C Reactive Protein (mg/dl) 0.36 (0.12–2.63) 0.24 (0.10–2.08) 0.452